Literature DB >> 9457432

Diarrheagenic Escherichia coli.

J P Nataro1, J B Kaper.   

Abstract

Escherichia coli is the predominant nonpathogenic facultative flora of the human intestine. Some E. coli strains, however, have developed the ability to cause disease of the gastrointestinal, urinary, or central nervous system in even the most robust human hosts. Diarrheagenic strains of E. coli can be divided into at least six different categories with corresponding distinct pathogenic schemes. Taken together, these organisms probably represent the most common cause of pediatric diarrhea worldwide. Several distinct clinical syndromes accompany infection with diarrheagenic E. coli categories, including traveler's diarrhea (enterotoxigenic E. coli), hemorrhagic colitis and hemolytic-uremic syndrome (enterohemorrhagic E. coli), persistent diarrhea (enteroaggregative E. coli), and watery diarrhea of infants (entero-pathogenic E. coli). This review discusses the current level of understanding of the pathogenesis of the diarrheagenic E. coli strains and describes how their pathogenic schemes underlie the clinical manifestations, diagnostic approach, and epidemiologic investigation of these important pathogens.

Entities:  

Mesh:

Year:  1998        PMID: 9457432      PMCID: PMC121379          DOI: 10.1128/CMR.11.1.142

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  624 in total

1.  Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

Authors:  H Peltola; A Siitonen; H Kyrönseppä; I Simula; L Mattila; P Oksanen; M J Kataja; M Cadoz
Journal:  Lancet       Date:  1991-11-23       Impact factor: 79.321

2.  Rapid Immunoassay for detection of Escherichia coli O157 directly from stool specimens.

Authors:  C H Park; N M Vandel; D L Hixon
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

3.  Construction and analysis of TnphoA mutants of enteropathogenic Escherichia coli unable to invade HEp-2 cells.

Authors:  M S Donnenberg; S B Calderwood; A Donohue-Rolfe; G T Keusch; J B Kaper
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  Isolation of Vero cytotoxin-producing Escherichia coli serotypes O9ab:H- and O101:H-carrying VT2 variant gene sequences from a patient with haemolytic uraemic syndrome.

Authors:  A Thomas; T Cheasty; H Chart; B Rowe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

5.  Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome.

Authors:  F Gunzer; H Böhm; H Rüssmann; M Bitzan; S Aleksic; H Karch
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Genes for CS2 pili of enterotoxigenic Escherichia coli and their interchangeability with those for CS1 pili.

Authors:  B J Froehlich; A Karakashian; H Sakellaris; J R Scott
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Neurally maintained hypersecretion in undernourished rat intestine activated by E. coli STa enterotoxin and cyclic nucleotides in vitro.

Authors:  H C Nzegwu; R J Levin
Journal:  J Physiol       Date:  1994-08-15       Impact factor: 5.182

8.  Survival rate of mice after transient colonization with Escherichia coli clones carrying variant Shiga-like toxin type II operons.

Authors:  J C Paton; A W Paton
Journal:  Microb Pathog       Date:  1996-06       Impact factor: 3.738

Review 9.  Adhesion and its role in the virulence of enteropathogenic Escherichia coli.

Authors:  D Law
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

10.  Aetiology of acute diarrhoea in hospitalized children in Rio de Janeiro City, Brazil.

Authors:  A H Mangia; A N Duarte; R Duarte; L A Silva; V L Bravo; M C Leal
Journal:  J Trop Pediatr       Date:  1993-12       Impact factor: 1.165

View more
  1433 in total

1.  Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt.

Authors:  L F Peruski; B A Kay; R A El-Yazeed; S H El-Etr; A Cravioto; T F Wierzba; M Rao; N El-Ghorab; H Shaheen; S B Khalil; K Kamal; M O Wasfy; A M Svennerholm; J D Clemens; S J Savarino
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

2.  Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelial cells.

Authors:  B P Hurley; M Jacewicz; C M Thorpe; L L Lincicome; A J King; G T Keusch; D W Acheson
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

3.  Phenylpropionic acid metabolism: a marker for enteropathogenic Escherichia coli clonal group 2 strains.

Authors:  V Monteiro-Neto; L R Trabulsi
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

4.  Transcriptional regulation of the orf19 gene and the tir-cesT-eae operon of enteropathogenic Escherichia coli.

Authors:  C Sánchez-SanMartín; V H Bustamante; E Calva; J L Puente
Journal:  J Bacteriol       Date:  2001-05       Impact factor: 3.490

5.  Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways.

Authors:  J Celli; M Olivier; B B Finlay
Journal:  EMBO J       Date:  2001-03-15       Impact factor: 11.598

6.  Diarrhea-associated diffusely adherent Escherichia coli.

Authors:  C Le Bouguénec
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

7.  Mechanical fractionation reveals structural requirements for enteropathogenic Escherichia coli Tir insertion into host membranes.

Authors:  A Gauthier; M de Grado; B B Finlay
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

8.  Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for alpha5beta1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules.

Authors:  J Guignot; M F Bernet-Camard; C Poüs; L Plançon; C Le Bouguenec; A L Servin
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 10.  Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  M S Donnenberg; T S Whittam
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.